XNAS 14 Jul, 2025 9:51 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jonathan Watkins | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 131,745 | 131,745 | - | - | Stock Option (right to Buy) | |
| Simon Ogier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 77,656 | 77,656 | - | - | Stock Option (right to Buy) | |
| Beverley Brown | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 33,741 | 33,741 | - | - | Stock Option (right to Buy) | |
| Melisa A. Denis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 23,915 | 23,915 | - | - | Stock Option (right to Buy) | |
| Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 23,915 | 23,915 | - | - | Stock Option (right to Buy) | |
| Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 170,320 | 170,320 | - | - | Stock Option (right to Buy) | |
| Klaas de Boer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 23,915 | 23,915 | - | - | Stock Option (right to Buy) | |
| Sriram Peruvemba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 23,915 | 23,915 | - | - | Stock Option (right to Buy) | |
| Barbra C. Keck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 75,660 | 75,660 | - | - | Stock Option (right to Buy) | |
| Simon Ogier | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | |
| Beverley Brown | Chief Scientist | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 49,000 | 49,000 | - | - | Employee stock option (Right to Buy) | |
| Melisa A. Denis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| Steven P. DenBaars | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 16,000 | 16,000 | - | - | Employee stock option (Right to Buy) | |
| Ian Tudor Jenks | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 165,000 | 165,000 | - | - | Employee stock option (Right to Buy) | |
| Klaas de Boer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| Sriram Peruvemba | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 20,000 | 20,000 | - | - | Employee stock option (Right to Buy) | |
| Barbra C. Keck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 100,000 | 100,000 | - | - | Employee stock option (Right to Buy) | |
| Klaas de Boer | Director | 30 May 2024 | 5,715 | 11,430 | - | - | Common Stock | ||
| Klaas de Boer | Director | 30 May 2024 | 50 | 0 | - | - | Series A-2 Convertible Preferred Stock |